Replies to post #229037 on Amarin Corp Plc (AMRN)

[marzan]

GILD has Renexa

GILD CEO said statnews today that they are in acquisition mode. They have 25B+ cash in hand. Plus they have a NASH combo clinical trial with V on going. Their cardio drug Renexa went on generic thus need a Rx CVD drug like V to replace their cardio space. Plus V can help their HIV and RA patients in their cardio and inflammation issues. A good across the board fit for GILD and hence B/O